ESR1 and neoplasm: Hypoactivation of estrogen receptor (ER) and hyperactivation of Hedgehog and PI3K/AKT/mTOR signaling cascades are involved in a transition to neoplasia, while the decreased activity of androgen receptor (AR) and Wnt pathways contribute to disease progression [111].